Background Radiotherapy after mastectomy to treat early breast cancer has been known
since the 1940s to reduce rates of local relapse. However, the routine use of postoperative …

Follicular lymphoma (FL) and diffuse large B-cell lymphoma (DLBCL) are the two most
common non-Hodgkin lymphomas (NHLs). Here we sequenced tumour and matched normal …

Background: The British Columbia randomized radiation trial was designed to determine
the survival impact of locoregional radiation therapy in premenopausal patients with lymph …

Purpose For more than two decades, cyclophosphamide, doxorubicin, vincristine, and
prednisone (CHOP) has been the standard therapy for diffuse large B-cell lymphoma (DLBCL). …

Some autoimmune disorders are increasingly recognized as risk factors for non-Hodgkin
lymphoma (NHL) overall, but large-scale systematic assessments of risk of NHL subtypes are …

Somatic missense mutations can initiate tumorogenesis and, conversely, anti-tumor cytotoxic
T cell (CTL) responses. Tumor genome analysis has revealed extreme heterogeneity …

BACKGROUND: Almost one-third of adult Canadians are at increased risk of disability,
disease and premature death because of being obese. In order to allocate limited health care …

We studied the role of multiple biomarkers in determining outcome in follicular lymphoma (FL),
concentrating in particular on the role of benign macrophages. The study group consisted …

Our objective in the study was to investigate the putative associations of specific pesticides
with non-Hodgkin’s Lymphoma [NHL; International Classification of Diseases, version 9 (ICD-…

Recent evidence suggests that there is etiologic heterogeneity among the various subtypes
of lymphoid neoplasms. However, epidemiologic analyses by disease subtype have proven …